• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病风险修饰基因不会影响细胞模型中 tau 聚集体的摄取、成核或维持。

Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models.

机构信息

Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

FEBS Open Bio. 2020 Sep;10(9):1912-1920. doi: 10.1002/2211-5463.12928.

DOI:10.1002/2211-5463.12928
PMID:32649026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7459407/
Abstract

Alzheimer's disease (AD) afflicts millions of people worldwide and is caused by accumulated amyloid beta and tau pathology. Progression of tau pathology in AD may utilize prion mechanisms of propagation in which pathological tau aggregates released from one cell are taken up by neighboring or connected cells and act as templates for their own replication, a process termed 'seeding'. We have used HEK293T cells to model various aspects of pathological tau propagation, including uptake of tau aggregates, induced seeding by exogenous aggregates, seeding caused by Lipofectamine-mediated delivery to the cell interior, and stable maintenance of aggregates in dividing cells. The factors that regulate these processes are not well understood, and we hypothesized that AD risk modifier genes might play a role. We identified 22 genes strongly linked to AD via meta-analysis of genome-wide association study (GWAS). We used CRISPR/Cas9 to individually knock out each gene in HEK293T cells and verified disruption using genomic sequencing. We then tested the effect of gene knockout in tau aggregate uptake, naked and Lipofectamine-mediated seeding, and aggregate maintenance in these cultured cell lines. GWAS gene knockouts had no effect in these models of tau pathology. With obvious caveats due to the model systems used, these results imply that the 22 AD risk modifier genes are unlikely to directly modulate tau uptake, seeding, or aggregate maintenance in a cell-autonomous fashion.

摘要

阿尔茨海默病(AD)影响着全球数百万人,其病因是淀粉样β和 tau 病理学的积累。AD 中 tau 病理学的进展可能利用了朊病毒传播的机制,即从一个细胞释放的病理性 tau 聚集体被邻近或连接的细胞摄取,并作为自身复制的模板,这一过程称为“播种”。我们已经使用 HEK293T 细胞来模拟病理性 tau 传播的各个方面,包括 tau 聚集体的摄取、外源性聚集体诱导的播种、通过脂质体介导的细胞内传递引起的播种,以及在分裂细胞中稳定维持聚集体。调节这些过程的因素尚不清楚,我们假设 AD 风险修饰基因可能起作用。我们通过全基因组关联研究(GWAS)的荟萃分析确定了与 AD 密切相关的 22 个基因。我们使用 CRISPR/Cas9 逐个敲除 HEK293T 细胞中的每个基因,并使用基因组测序验证了基因的破坏。然后,我们在这些培养细胞系中测试了基因敲除对 tau 聚集体摄取、裸和脂质体介导播种以及聚集体维持的影响。GWAS 基因敲除对这些 tau 病理学模型没有影响。由于使用的模型系统存在明显的局限性,这些结果表明 22 个 AD 风险修饰基因不太可能以细胞自主的方式直接调节 tau 的摄取、播种或聚集体的维持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/1e64f0b11788/FEB4-10-1912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/b5832b8f7e28/FEB4-10-1912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/7450b8cb41ce/FEB4-10-1912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/0db29394c869/FEB4-10-1912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/d669efce3ee0/FEB4-10-1912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/1e64f0b11788/FEB4-10-1912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/b5832b8f7e28/FEB4-10-1912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/7450b8cb41ce/FEB4-10-1912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/0db29394c869/FEB4-10-1912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/d669efce3ee0/FEB4-10-1912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a7/7459407/1e64f0b11788/FEB4-10-1912-g005.jpg

相似文献

1
Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models.阿尔茨海默病风险修饰基因不会影响细胞模型中 tau 聚集体的摄取、成核或维持。
FEBS Open Bio. 2020 Sep;10(9):1912-1920. doi: 10.1002/2211-5463.12928.
2
Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau α-synuclein and β-amyloid aggregates.特定糖胺聚糖链长和硫酸化模式是细胞摄取 tau、α-突触核蛋白和β-淀粉样蛋白聚集体所必需的。
J Biol Chem. 2018 Jul 6;293(27):10826-10840. doi: 10.1074/jbc.RA117.000378. Epub 2018 May 11.
3
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.在向中枢神经系统注射阿尔茨海默病脑源性病理性tau蛋白或合成突变型人tau蛋白原纤维后,绿色荧光蛋白标记的突变型人tau转基因小鼠出现tau蛋白病。
J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6.
4
Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.聚集的 Tau 激活 NLRP3-ASC 炎症小体,加剧体内外源性和非外源性 Tau 病理。
Acta Neuropathol. 2019 Apr;137(4):599-617. doi: 10.1007/s00401-018-01957-y. Epub 2019 Feb 5.
5
Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.预先聚集的β-淀粉样蛋白对Tau蛋白纤维化的异型播种为体内Tau病理的朊病毒样播种和传播提供了有效的种子。
Acta Neuropathol. 2016 Apr;131(4):549-69. doi: 10.1007/s00401-015-1525-x. Epub 2016 Jan 6.
6
Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.Aβ 诱导的阿尔茨海默病相关 tau 病理扩散加速及其与朊病毒蛋白的关系。
Acta Neuropathol. 2019 Dec;138(6):913-941. doi: 10.1007/s00401-019-02053-5. Epub 2019 Aug 14.
7
Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.比较体外和体内来源的 Tau 纤维中大小分布和(Pro249-Ser258)表位暴露情况。
BMC Mol Cell Biol. 2020 Nov 12;21(1):81. doi: 10.1186/s12860-020-00320-y.
8
The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.趋化因子样受体 1 缺乏通过调节 Tau 成核改善 AD 小鼠的认知缺陷并减轻 Tau 过度磷酸化。
J Neurosci. 2020 Sep 2;40(36):6991-7007. doi: 10.1523/JNEUROSCI.0455-20.2020. Epub 2020 Aug 12.
9
A synthetic heparinoid blocks Tau aggregate cell uptake and amplification.一种合成肝素类似物可阻止 Tau 聚集物的细胞摄取和扩增。
J Biol Chem. 2020 Mar 6;295(10):2974-2983. doi: 10.1074/jbc.RA119.010353. Epub 2020 Jan 23.
10
Specific detection of tau seeding activity in Alzheimer's disease using rationally designed biosensor cells.利用合理设计的生物传感器细胞特异性检测阿尔茨海默病中的 tau 种子活性。
Mol Neurodegener. 2023 Aug 8;18(1):53. doi: 10.1186/s13024-023-00643-2.

引用本文的文献

1
PICALM and Alzheimer's Disease: An Update and Perspectives.载脂蛋白 E 与阿尔茨海默病:研究进展与展望
Cells. 2022 Dec 10;11(24):3994. doi: 10.3390/cells11243994.
2
CRISPRi screening reveals regulators of tau pathology shared between exosomal and vesicle-free tau.CRISPRi 筛选揭示了外泌体和无囊泡 tau 之间 tau 病理的共同调节因子。
Life Sci Alliance. 2022 Oct 31;6(1). doi: 10.26508/lsa.202201689. Print 2023 Jan.
3
The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification.外源性 tau 种子的双重命运:溶酶体清除与细胞质扩增。

本文引用的文献

1
A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology.tau 平衡特征与兴奋性神经元的细胞和区域易感性有关,易感性与 tau 病理学有关。
Nat Neurosci. 2019 Jan;22(1):47-56. doi: 10.1038/s41593-018-0298-7. Epub 2018 Dec 17.
2
Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.tau 种子活性首先出现在(transentorhinal/entorhinal)区域,并且可预测阿尔茨海默病和 PART 中的磷酸化 tau 病理学。
Acta Neuropathol. 2018 Jul;136(1):57-67. doi: 10.1007/s00401-018-1855-6. Epub 2018 May 11.
3
J Biol Chem. 2022 Jun;298(6):102014. doi: 10.1016/j.jbc.2022.102014. Epub 2022 May 5.
4
Application of CRISPR/Cas9 in Alzheimer's Disease.CRISPR/Cas9在阿尔茨海默病中的应用。
Front Neurosci. 2021 Dec 21;15:803894. doi: 10.3389/fnins.2021.803894. eCollection 2021.
Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau α-synuclein and β-amyloid aggregates.
特定糖胺聚糖链长和硫酸化模式是细胞摄取 tau、α-突触核蛋白和β-淀粉样蛋白聚集体所必需的。
J Biol Chem. 2018 Jul 6;293(27):10826-10840. doi: 10.1074/jbc.RA117.000378. Epub 2018 May 11.
4
Selective neuronal vulnerability in Parkinson disease.帕金森病中的选择性神经元易损性。
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113. doi: 10.1038/nrn.2016.178.
5
Antibody Therapeutics Targeting Aβ and Tau.靶向 Aβ 和 Tau 的抗体治疗药物
Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a024331. doi: 10.1101/cshperspect.a024331.
6
FRET and Flow Cytometry Assays to Measure Proteopathic Seeding Activity in Biological Samples.用于测量生物样品中蛋白病种子活性的荧光共振能量转移和流式细胞术检测
Methods Mol Biol. 2017;1523:349-359. doi: 10.1007/978-1-4939-6598-4_23.
7
Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.tau蛋白朊病毒株决定体内细胞病理学模式、进展速率和区域易损性
Neuron. 2016 Nov 23;92(4):796-812. doi: 10.1016/j.neuron.2016.09.055. Epub 2016 Oct 27.
8
Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.来自阿尔茨海默病和慢性创伤性脑病患者的tau朊病毒在培养细胞中传播。
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8187-E8196. doi: 10.1073/pnas.1616344113. Epub 2016 Nov 28.
9
Prions, Chaperones, and Proteostasis in Yeast.酵母中的朊病毒、伴侣蛋白与蛋白质稳态
Cold Spring Harb Perspect Biol. 2017 Feb 1;9(2):a023663. doi: 10.1101/cshperspect.a023663.
10
A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer's disease.健康大脑中的蛋白质稳态特征再现了阿尔茨海默病对组织的易损性。
Sci Adv. 2016 Aug 10;2(8):e1600947. doi: 10.1126/sciadv.1600947. eCollection 2016 Aug.